PTK2 and neoplasm: The frequency of immune cells (figure 7D and online supplemental figure 8) and effector CD8 T-cells (effCD8) (figure 7E and online supplemental figure 8) infiltrating into FAK-/-STAT3shRNA tumours was also significantly increased.